Literature DB >> 33622291

Knowledge and attitude of pregnant women towards preeclampsia and its associated factors in South Gondar Zone, Northwest Ethiopia: a multi-center facility-based cross-sectional study.

Maru Mekie1, Dagne Addisu2, Minale Bezie2, Abenezer Melkie2, Dejen Getaneh3, Wubet Alebachew Bayih3, Wubet Taklual4.   

Abstract

BACKGROUND: Preeclampsia has the greatest impact on maternal mortality which complicates nearly a tenth of pregnancies worldwide. It is one of the top five maternal mortality causes and responsible for 16 % of direct maternal death in Ethiopia. Little is known about the level of knowledge and attitude towards preeclampsia in Ethiopia. This study was designed to assess the knowledge and attitude towards preeclampsia and its associated factors in South Gondar, Northwest Ethiopia.
METHODS: A multicenter facility-based cross-sectional study was implemented in four selected hospitals of South Gondar Zone among 423 pregnant women. Multistage random sampling and systematic random sampling techniques were used to select the study sites and the study participants respectively. Data were entered in EpiData version 3.1 while cleaned and analyzed by Statistical Package for Social Sciences (SPSS) version 23. Descriptive and inferential statistics were performed. Adjusted odds ratio with 95 % confidence interval were used to identify the significance of the association between the level of knowledge on preeclampsia and its predictors.
RESULTS: In this study, 118 (28.8 %), 120 (29.3 %) of the study participants had good knowledge and a positive attitude towards preeclampsia respectively. The likelihood of having good knowledge on preeclampsia was found to be low among women with no education (AOR = 0.22, 95 % CI (0.06, 0.85)), one antenatal care visit (ANC) (AOR = 0.13, 95 % CI (0.03, 0.59)). Whereas, those who booked for ANC in the first trimester (AOR = 6.59, 95 % CI (1.43, 30.33)), gave the last birth at a health facility (AOR = 2.61, 955 CI (1.03, 6.61)), and experienced a complication during previous births (AOR = 3.67, 95 % CI (1.78, 7.57)) were more likely to be knowledgeable on preeclampsia.
CONCLUSIONS: No formal education and not attending four ANC visits were associated with poor knowledge of preeclampsia. While participants who visited health facilities during the first trimester, who gave birth at health facilities, and those who experienced a complication in previous births were more likely to be knowledgeable on preeclampsia. Improving the numbers of ANC visits and encouraging facility delivery are important measures to improve women's knowledge on preeclampsia. Health education regarding preeclampsia risk factors, symptoms, and complications shall be emphasized.

Entities:  

Keywords:  Attitude; Ethiopia; Knowledge; Maternal mortality; Preeclampsia

Mesh:

Year:  2021        PMID: 33622291      PMCID: PMC7903706          DOI: 10.1186/s12884-021-03647-2

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  18 in total

1.  Knowledge of pre-eclampsia in women living in Makole Ward, Dodoma, Tanzania.

Authors:  Angela Ruth Savage; Lujani Hoho
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 2.  Pre-eclampsia in low and middle income countries.

Authors:  Tabassum Firoz; Harshad Sanghvi; Mario Merialdi; Peter von Dadelszen
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-05-17       Impact factor: 5.237

Review 3.  The global impact of pre-eclampsia and eclampsia.

Authors:  Lelia Duley
Journal:  Semin Perinatol       Date:  2009-06       Impact factor: 3.300

4.  Women's experiences of preeclampsia: Australian action on preeclampsia survey of women and their confidants.

Authors:  C East; K Conway; W Pollock; N Frawley; S Brennecke
Journal:  J Pregnancy       Date:  2011-03-23

5.  Women's Knowledge, Attitudes and Behavior about Maternal Risk Factors in Pregnancy.

Authors:  Giuseppe Esposito; Rossella Ambrosio; Francesco Napolitano; Gabriella Di Giuseppe
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

6.  Community perceptions of pre-eclampsia and eclampsia in southern Mozambique.

Authors:  Helena Boene; Marianne Vidler; Charfudin Sacoor; Abel Nhama; Ariel Nhacolo; Cassimo Bique; Pedro Alonso; Diane Sawchuck; Rahat Qureshi; Eusébio Macete; Clara Menéndez; Peter von Dadelszen; Esperança Sevene; Khátia Munguambe
Journal:  Reprod Health       Date:  2016-06-08       Impact factor: 3.223

Review 7.  Current best practice in the management of hypertensive disorders in pregnancy.

Authors:  Rosemary Townsend; Patrick O'Brien; Asma Khalil
Journal:  Integr Blood Press Control       Date:  2016-07-27

8.  Knowledge of hypertensive disorders in pregnancy of Moroccan women in Morocco and in the Netherlands: a qualitative interview study.

Authors:  Fatima Ouasmani; Bernice Engeltjes; Bouchra Haddou Rahou; Ouafae Belayachi; Corine Verhoeven
Journal:  BMC Pregnancy Childbirth       Date:  2018-08-22       Impact factor: 3.007

9.  Awareness of pregnancy induced hypertension among pregnant women in Tigray Regional State, Ethiopia.

Authors:  Abadi Kidanemariam Berhe; Abiodun Olatunbosun Ilesanmi; Christopher Odianosen Aimakhu; Afework Mulugeta Bezabih
Journal:  Pan Afr Med J       Date:  2020-03-11

10.  Knowledge of preeclampsia and its associated factors among pregnant women: a possible link to reduce related adverse outcomes.

Authors:  Linda A Fondjo; Vivian E Boamah; Adelaide Fierti; Dorcas Gyesi; Eddie-Williams Owiredu
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-02       Impact factor: 3.007

View more
  1 in total

1.  Perception towards preeclampsia and perceived barriers to early health-seeking among pregnant women in selected Hospitals of South Gondar Zone, Northwest Ethiopia: A qualitative study.

Authors:  Maru Mekie; Minale Bezie; Abenezer Melkie; Dagne Addisu; Ermias Sisay Chanie; Wubet Alebachew Bayih; Shimeles Biru; Mekonnen Hailie; Tigist Seid; Enyew Dagnew; Tewachew Muche; Eshetie Molla Alemu
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.